IS Pharma plc placing at a premium gives confidence and we get a dividend as well
Abingworth clearly likes what it sees in ISPH and is now the largest shareholder in the Group with a 13% holding.
IS Pharma continues to focus on its strategy of growth through the acquisition, development and growth of late stage speciality products. Given the strong and sustainable increase in revenues and profits, together with a further strengthened balance sheet, ISPH has also announced an intention to introduce a maiden dividend.
We whole heartedly…
Previous article Next article